MARC FEINBERG
BOCA RATON, FL NPI 1255422127
Browse related groups: FL ABBVIE INC. All categories
General Payments — all program years on this page
$25,271.12
- Category: General Payments
- Program years: PY2018–2024
- Record count: 632
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $901.17 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $901.17 | 38 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.87 | 8 |
| ARGENX US, INC. | $87.39 | 3 |
| PFIZER INC. | $66.65 | 3 |
| Lilly USA, LLC | $60.84 | 3 |
| CSL Behring | $54.55 | 2 |
| Lundbeck LLC | $52.46 | 2 |
| Alexion Pharmaceuticals, Inc. | $51.69 | 2 |
| EMD Serono, Inc. | $49.14 | 2 |
| Genentech USA, Inc. | $28.27 | 1 |
| REVANCE THERAPEUTICS, INC. | $27.67 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.07 | 1 |
| SCILEX PHARMACEUTICALS INC. | $24.30 | 1 |
| Neurocrine BioSciences, Inc. | $22.56 | 1 |
| MDD US Operations, LLC | $22.40 | 1 |
| ACADIA Pharmaceuticals Inc | $22.32 | 1 |
| Merz Pharmaceuticals, LLC | $21.18 | 1 |
| Vanda Pharmaceuticals Inc. | $21.17 | 1 |
| Abbott Laboratories | $20.46 | 1 |
| Celgene Corporation | $17.78 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $15.74 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.66 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.